# Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer

> **NCT01845792** · PHASE2 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 7 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Cabazitaxel with Abiraterone Acetate
- **DRUG:** Cabazitaxel

## Key facts

- **NCT ID:** NCT01845792
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2018-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845792, "Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01845792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*